CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on breast cancer by developing a comprehensive glycomics workflow to create patient-specific 'GlycoMaps'. It aims to enhance precision medicine through better understanding of tumor glycosylation and its impact on treatment responses using patient-derived organoids.
Breast Cancer is the most commonly diagnosed cancer in Europe and remains the first cause of cancer death in women (nearly 92,000 deaths in 2020).
Precision medicine uses data-driven insights to reflect the heterogeneity of patients and improve cancer care by offering actionable oncology treatment options.
Tumour tissue heterogeneity is the leading cause for inter-patient variation in treatment response.
One of the largest sources of tissue heterogeneity arises from post-translational glycosylat…
OSLOMET - OSLO METROPOLITAN UNIVERSITY
OSLOMET - STORBYUNIVERSITETET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
